Ajanta Pharma Limited has informed the Exchange about Schedule of meet
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has informed the exchanges that it will release its Q3 FY2026 unaudited financial results on January 30, 2026, post its Board meeting. The company will host an earnings conference call on the same day at 16:30 hrs IST, lasting about an hour, where the leadership team will discuss financial performance and take questions. The call is accessible globally, with toll-free numbers for USA, UK, Hong Kong, and Singapore, plus a Diamond Pass registration link for faster access. A playback of the call will be available on the company's website roughly 2 hours after the call ends.
This is a routine regulatory disclosure and does not have a direct impact on the stock price. However, the Q3 results and the management commentary during the call could influence investor sentiment and trading activity around January 30, 2026.